re: refresher Sorry refresher , didnt mean to make it sound like the 80% tumour reduction in a stage 4 they have achieved is not outstanding , but I just think that once they get onto their chosen target cancers where the drug works best that even more is possible . Then consider that future trials will be against earlier stage patients .
- Forums
- ASX - By Stock
- SBP
- grant of us patent
SBP
solbec pharmaceuticals limited